CATALYST PHARMACEUTICALS, INC.
Pharmaceutical Preparations · 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL 33134
공식 등기 데이터
0팔로워
2002설립
CATALYST PHARMACEUTICALS, INC. 소개
Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company based in Coral Gables, Florida, United States. The company develops medicines for rare diseases, including the phosphate salt of amifampridine for the treatment of Lambert–Eaton myasthenic syndrome (LEMS). The drug is referred to under the trade name Firdapse, which was approved by the FDA for approved use in children 6 years and older with LEMS in addition to the prior approval for use in adults with LEMS on November 28, 2018. Firdapse commercially launched in January 2019.
Source: Wikipedia
산업Pharmaceutical Preparations
본사355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL 33134
설립2002
법적 형태C Corporation
상태운영 중
특허특허 4건
VAMOROLONE SOLID ORAL DOSAGE FORMSWO2026035689A1 · 2026
METHOD FOR TREATING BOTULINUM TOXIN POISONINGWO2023023463A1 · 2023
주요 수치
법적 정보
| 법인명 | CATALYST PHARMACEUTICALS, INC. |
|---|---|
| 법적 형태 | C Corporation |
| SEC CIK | 1369568SEC EDGAR에서 보기 ↗ |
| 업종 코드(SIC) | 2834 |
| 등기 주소 | 355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL 33134 |
| 상태 | 운영 중 |
출처: SEC EDGAR · 2026년 10월 15일 업데이트
연락처 및 링크
위치
355 ALHAMBRA CIRCLE, SUITE 801, CORAL GABLES, FL 33134
귀하의 회사인가요?
이 페이지를 무료로 신청하여 로고, 제품, 사진, 채용 공고를 추가하고 리뷰에 답변하세요.
이 페이지 신청